Literature DB >> 9556472

Heparin prophylaxis for medical patients?

F A Lederle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9556472     DOI： 10.7326/0003-4819-128-9-199805010-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

Review 1.  Deep venous thrombosis prophylaxis in patients with heart disease.

Authors:  B K Shively
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

2.  Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatients.

Authors:  José Labarère; Jean-Luc Bosson; Jean-François Bergmann; Nathalie Thilly
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

3.  Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.

Authors:  Mingjin Yang; Ying Xu; Hong Chen; Zhibo Xu; Fengming Luo
Journal:  Inflammopharmacology       Date:  2019-10-31       Impact factor: 4.473

4.  Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey.

Authors:  D Cook; J McMullin; R Hodder; M Heule; J Pinilla; P Dodek; T Stewart
Journal:  Crit Care       Date:  2001-09-26       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.